Rapid cognitive decline in Alzheimer's disease: a literature review
- PMID: 24423219
- DOI: 10.3109/09540261.2013.859128
Rapid cognitive decline in Alzheimer's disease: a literature review
Abstract
Background: The rate of cognitive decline in Alzheimer's disease (AD) varies considerably between individuals. Predicting rapid cognitive decline might help clinicians provide prognostic information, select subjects for trial intervention and/or reduce costs.
Methods: PubMed and PsycINFO were searched for all the English written studies published until the end of 2010 on rapid cognitive decline in AD and factors associated with it.
Results: More than 300 individual articles were retrieved. We selected 82 relevant studies. The main findings of these papers are that younger, more educated and more impaired patients are more likely to show rapid cognitive decline. ApoE alleles seem not to modify the velocity of clinical progression of dementia, or at most could have a very small effect. No inference can be made for all the other variables analysed.
Conclusions: There are many studies on rapid cognitive decline. Results are heterogeneous and often contradictory. No reliable conclusions about factors that may be associated with rapid cognitive decline can yet be drawn.
Similar articles
-
Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline.Brain. 2014 Apr;137(Pt 4):1167-75. doi: 10.1093/brain/awu035. Epub 2014 Feb 27. Brain. 2014. PMID: 24578544
-
Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.Arch Neurol. 2005 Mar;62(3):454-9. doi: 10.1001/archneur.62.3.454. Arch Neurol. 2005. PMID: 15767511
-
Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.Dement Geriatr Cogn Disord. 2006;22(1):73-82. doi: 10.1159/000093316. Epub 2006 May 12. Dement Geriatr Cogn Disord. 2006. PMID: 16699282
-
Diet and Alzheimer's disease risk factors or prevention: the current evidence.Expert Rev Neurother. 2011 May;11(5):677-708. doi: 10.1586/ern.11.56. Expert Rev Neurother. 2011. PMID: 21539488 Review.
-
Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.Clin Ther. 2006 Jul;28(7):991-1001. doi: 10.1016/j.clinthera.2006.07.006. Clin Ther. 2006. PMID: 16990077 Review.
Cited by
-
Demographic and clinical characteristics related to cognitive decline in Alzheimer disease in China: A multicenter survey from 2011 to 2014.Medicine (Baltimore). 2016 Jun;95(26):e3727. doi: 10.1097/MD.0000000000003727. Medicine (Baltimore). 2016. PMID: 27367978 Free PMC article.
-
Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years.JAMA Neurol. 2019 Feb 1;76(2):152-160. doi: 10.1001/jamaneurol.2018.3616. JAMA Neurol. 2019. PMID: 30452522 Free PMC article.
-
Edaravone injection ameliorates cognitive deficits in rat model of Alzheimer's disease.Neurol Sci. 2015 Nov;36(11):2067-72. doi: 10.1007/s10072-015-2314-y. Epub 2015 Jul 12. Neurol Sci. 2015. PMID: 26163224
-
Therapeutic effect of transmembrane TAT-tCNTF via Erk and Akt activation using in vitro and in vivo models of Alzheimer's disease.Int J Clin Exp Pathol. 2018 Apr 1;11(4):1855-1865. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31938292 Free PMC article.
-
Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes.Int J Geriatr Psychiatry. 2018 Aug;33(8):1057-1064. doi: 10.1002/gps.4893. Epub 2018 May 15. Int J Geriatr Psychiatry. 2018. PMID: 29761569 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous